| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/25/2001 | WO2001035989A2 Use of anti-idiotypical antibodies as vaccines against cancer |
| 05/25/2001 | WO2001035980A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 05/25/2001 | WO2001035970A1 Viruses for the treatment of cellular proliferative disorders |
| 05/25/2001 | WO2001035969A1 T-cells specific for polymorphic proteins on malignant cells |
| 05/25/2001 | WO2001035903A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001035899A2 Inhibitors of helicobacter pylori induced gastrointestinal diseases |
| 05/25/2001 | WO2001035811A2 Methods of diagnosing and determining prognosis of breast cancer |
| 05/25/2001 | WO2001035810A2 Cancer immunotherapy and diagnosis using cytochrome p450 1b1 |
| 05/25/2001 | WO2001035733A1 Method of acquiring immunological tolerance |
| 05/25/2001 | WO2001013898A3 Pharmaceutical formulations with different release times |
| 05/25/2001 | WO2001004349A3 Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease |
| 05/25/2001 | WO2000077041A3 Peptides from decorin binding protein and their uses |
| 05/25/2001 | WO2000073345A3 Antibodies specific for mycobacterial polypeptides and uses thereof |
| 05/25/2001 | WO2000073338A8 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 05/25/2001 | WO2000070024A3 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses |
| 05/25/2001 | WO2000067793A8 Death domain containing receptor 4 |
| 05/25/2001 | WO2000064469A3 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 05/25/2001 | WO2000021558A9 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 05/25/2001 | WO2000010588A3 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 05/25/2001 | CA2720361A1 Viruses for the treatment of cellular proliferative disorders |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2392109A1 Mammalian receptor proteins; related reagents and methods |
| 05/25/2001 | CA2391927A1 Novel use of antibodies as vaccines |
| 05/25/2001 | CA2391925A1 Antibodies |
| 05/25/2001 | CA2391908A1 Novel polypeptides and nucleic acids encoding same |
| 05/25/2001 | CA2391885A1 Polypeptides and nucleic acids encoding same |
| 05/25/2001 | CA2391560A1 The genome of the hiv-1 inter-subtype (c/b') and use thereof |
| 05/25/2001 | CA2391530A1 Tr3-specific binding agents and methods for their use |
| 05/25/2001 | CA2391450A1 Targeted delivery of therapeutic and diagnostic moieties |
| 05/25/2001 | CA2391212A1 Methods and compositions for identifying disease markers |
| 05/25/2001 | CA2390882A1 Cancer immunotherapy and diagnosis using cytochrome p450 1b1 |
| 05/25/2001 | CA2390607A1 Materials and methods for detection and treatment of breast cancer |
| 05/25/2001 | CA2390548A1 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | CA2390148A1 Immunotherapy |
| 05/25/2001 | CA2390031A1 Double-stranded rna receptor (dsrna-r) and methods relating thereto |
| 05/25/2001 | CA2389862A1 Human monoclonal antibody against tgf-.beta.ii receptor and medicinal use thereof |
| 05/25/2001 | CA2389851A1 Human igm antibodies to chemokine receptors |
| 05/25/2001 | CA2389662A1 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/25/2001 | CA2389289A1 Mammalian toxicological response markers |
| 05/25/2001 | CA2388865A1 Novel g protein-coupled receptors |
| 05/25/2001 | CA2388807A1 Viruses for the treatment of cellular proliferative disorders |
| 05/25/2001 | CA2386341A1 Heteroclitic analogs and related methods |
| 05/25/2001 | CA2359577A1 Antibodies and fv fragment recognizing antigen ior c2 |
| 05/24/2001 | US20010001712 Causing apoptosis on myeloid cells through binding to the myeloid cells |
| 05/24/2001 | US20010001709 Methods for enhancing the production of viral vaccines in cell culture |
| 05/23/2001 | EP1101820A1 Pentraxin I and Pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/23/2001 | EP1100950A1 Gastrointestinal bacterial antibody factories |
| 05/23/2001 | EP1100942A2 Herpes virus vectors for dendritic cells |
| 05/23/2001 | EP1100926A1 TRIMER OF HIV $i(ENV) GENE EXPRESSION PRODUCT |
| 05/23/2001 | EP1100925A1 Attenuated equine herpesvirus |
| 05/23/2001 | EP1100922A1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 05/23/2001 | EP1100921A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/23/2001 | EP1100920A2 Nucleic acids and proteins from group b streptococcus |
| 05/23/2001 | EP1100919A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 05/23/2001 | EP1100918A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/23/2001 | EP1100917A1 Granulocytic ehrlichia genes and uses thereof |
| 05/23/2001 | EP1100913A1 Mekk1 serine threonine kinases -interacting fha forkhead associated domain protein 1 (mif1) |
| 05/23/2001 | EP1100907A2 Human cytoskeletal proteins |
| 05/23/2001 | EP1100906A1 Kdel receptor inhibitors |
| 05/23/2001 | EP1100901A1 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 05/23/2001 | EP1100896A1 Dna encoding snorf33 receptor |
| 05/23/2001 | EP1100887A1 Growth differentiation factor-11 |
| 05/23/2001 | EP1100886A1 Tumor necrosis factor-gamma |
| 05/23/2001 | EP1100882A1 Human protein kinase h2lau20 |
| 05/23/2001 | EP1100829A2 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases |
| 05/23/2001 | EP1100819A2 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 05/23/2001 | EP1100818A1 Inhibitors of hiv membrane fusion |
| 05/23/2001 | EP1100817A1 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 05/23/2001 | EP1100771A1 Compounds and compositions for delivering active agents |
| 05/23/2001 | EP1100547A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 05/23/2001 | EP1100546A1 Dna cytokine vaccines and use of same for protective immunity against multiple sclerosis |
| 05/23/2001 | EP1100544A1 Allogeneic cellular immunogens useful as cancer vaccines |
| 05/23/2001 | EP1100537A2 Multivalent human-bovine rotavirus vaccine |
| 05/23/2001 | EP1100536A2 Live attenuated salmonella vaccines to control avian pathogens |
| 05/23/2001 | EP1100535A1 Targeting pharmaceutical agents to injured tissues |
| 05/23/2001 | EP1100533A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/23/2001 | EP1100529A1 Thymosin beta 4 promotes wound repair |
| 05/23/2001 | EP1100526A2 USE OF HC gp-39 IN IMMUNE DISEASES |
| 05/23/2001 | EP1100522A1 Pulmonary delivery of active agents |
| 05/23/2001 | EP1100518A1 COMPOSITION AND METHOD OF TREATING DISEASE WITH EXTRACT OF $i(MUSACEAS) |
| 05/23/2001 | EP1100515A1 $i(EX VIVO) TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS |
| 05/23/2001 | EP1100468A1 Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| 05/23/2001 | EP1100461A2 Method of vaccination of newly hatched poultry |
| 05/23/2001 | EP0689600B1 Process to induce the death of tumor cells |
| 05/23/2001 | EP0623170B1 Vaccines based on streptokinase |
| 05/23/2001 | EP0572433B1 Antigen-presenting capsid with fusion ms2-coat protein |
| 05/23/2001 | DE19943786A1 Antiviral agent, e.g. vaccine, antibody, agent that inhibits viral replication, transcription or translation, useful for preventing or treating tumors (or conditions which may become tumorous) associated with viral infections |
| 05/23/2001 | CN1296416A Adjuvant compositions |
| 05/23/2001 | CN1296415A IL-12 stimulation of neonatal immunity |
| 05/23/2001 | CN1296414A IL-12 enhancement of immune responses to T-isdependent antigens |
| 05/23/2001 | CN1296013A Novel human membrane granulosa protein and coding sequence |
| 05/23/2001 | CN1295863A Immune milk products capable of resisting respiratory tract disease |
| 05/22/2001 | US6235888 Isolated nucleic acid |
| 05/22/2001 | US6235883 Human monoclonal antibodies to epidermal growth factor receptor |
| 05/22/2001 | US6235714 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 05/22/2001 | US6235713 Vascular endothelial growth factor-D (VEGF-D) polypeptides |
| 05/22/2001 | US6235525 Nucleotide sequence; diagnosis; vaccines; transfected cell line |
| 05/22/2001 | US6235523 Vector having nucleic acid encoding a human papillomavirus-16 e7 antigen lacking the rb protein binding site and operably linked to a cytomegalo virus promoter; vaccines |
| 05/22/2001 | US6235518 Recombinant immunogenic actinomycetale |
| 05/22/2001 | US6235288 An hepatitis b virus immunogenic peptide comprising a peptide of 50 amino acids or less in length comprises at least seven contiguous amino acids of specific amino acid sequences, binds to an hla molecule to form a complex |